XML 35 R29.htm IDEA: XBRL DOCUMENT v2.4.1.9
Earnings Per Common Share Attributable to Common Shareholders (Tables)
3 Months Ended
Mar. 29, 2015
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earning Per Share
The following table provides the detailed calculation of Earnings per common share (EPS):
 
 
Three Months Ended
(IN MILLIONS)
 
March 29,
2015

 
March 30,
2014

EPS Numerator––Basic
 
 
 
 
Income from continuing operations
 
$
2,376

 
$
2,265

Less: Net income attributable to noncontrolling interests
 
6

 
9

Income from continuing operations attributable to Pfizer Inc.
 
2,371

 
2,256

Less: Preferred stock dividends––net of tax
 

 

Income from continuing operations attributable to Pfizer Inc. common shareholders
 
2,370

 
2,256

Discontinued operations––net of tax
 
5

 
73

Less: Discontinued operations––net of tax, attributable to noncontrolling interests
 

 

Discontinued operations––net of tax, attributable to Pfizer Inc. common shareholders
 
5

 
73

Net income attributable to Pfizer Inc. common shareholders
 
$
2,375

 
$
2,329

EPS Numerator––Diluted
 
 

 
 

Income from continuing operations attributable to Pfizer Inc. common shareholders and assumed conversions
 
$
2,371

 
$
2,256

Discontinued operations––net of tax, attributable to Pfizer Inc. common shareholders and assumed conversions
 
5

 
73

Net income attributable to Pfizer Inc. common shareholders and assumed conversions
 
$
2,376

 
$
2,329

EPS Denominator
 
 

 
 

Weighted-average number of common shares outstanding––Basic
 
6,203

 
6,389

Common-share equivalents: stock options, stock issuable under employee compensation plans, convertible preferred stock and accelerated share repurchase agreement
 
90

 
87

Weighted-average number of common shares outstanding––Diluted
 
6,292

 
6,476

Stock options that had exercise prices greater than the average market price of our common stock issuable under employee compensation plans(a)
 
34

 
43

(a) 
These common stock equivalents were outstanding for the three months ended March 29, 2015 and March 30, 2014, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.